MedTrace Logo

Ocytocine and Cerebral Activation in Relation With Attachement

NCT02847143 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-10-02

No results posted yet for this study

Summary

The study aims to characterize the cerebral activation modifications related to nasal oxytocin administration during vizualisation of distress images in population of healthy people with different attachement styles.

Conditions

  • Attachement Style

Interventions

DRUG

nasal oxytocin or placebo

nasal administration of oxytocin or palcebo 45 min befor fMRI session

DEVICE

fMRI

FMRI during emotional image visualization

BEHAVIORAL

Attachement scale interview (ASI)

this scale is used to determine the attachement style of each participant

BEHAVIORAL

psychometric scales

self adminstrated questionnaires which asses the level of anxiety (Spielberger State-trait anxiety interview-STAI), depression (Beck depression inventory-BDI) and alexithymia (Toronta Alexuthymia scale-TAS 20)

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Besancon

    lead OTHER

Principal Investigators

  • Lauriane VULLIEZ-COADY, MD · Centre Hospitalier Universitaire de Besancon

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-04-09
Primary Completion
2018-04-27
Completion
2018-04-27

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02847143 on ClinicalTrials.gov